CRONOS GROUP INC. Gains Losses On Fair Value Adjustment Biological Assets
CRONOS GROUP INC. (CRON) reported Gains Losses On Fair Value Adjustment Biological Assets of CAD 11.57 million for the 12-month period ending 2018-12-31, per its 40-F filed 2019-03-26.
Discontinued › Income Statement › Other Income
ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets · last filed 2019-03-26
| Period end | Gains Losses On Fair Value Adjustment Biological Assets 12 month | Gains Losses On Fair Value Adjustment Biological Assets 12 month as first filed |
|---|---|---|
| 2018-12-31 | 11.57M CAD 40-F · filed 2019-03-26 | |
| 2017-12-31 | 7.64M CAD 40-F · filed 2019-03-26 | 11.62M CAD 40-F · filed 2018-04-30 |
| 2016-12-31 | 2.18M CAD 40-F · filed 2018-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |